State of peroxidation in the brain and liver in experimental diabetes and its correction possibility with niacin-oxyethylendiphosphonatogermanate

Authors

DOI:

https://doi.org/10.14739/2310-1210.2023.5.283612

Keywords:

streptozotocin, diabetes, lipid peroxidation, antioxidant enzymes, membranes, insulin

Abstract

The development of pharmacological methods to control oxidant stress manifestations in diabetes can be achieved using organic complex germanium compounds. One of the promising compounds is niacin-oxyethylenediphosphonategermanate (MIGU-4), which is an effective corrector of lipid metabolism and a stabilizer of the lipid layer of erythrocyte and hepatocyte membranes in the streptozotocin-induced diabetic model.

The aim of the work is to determine the dynamics of the malondialdehyde (MDA) content, the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPO) in the brain tissue, as well as the diene conjugate (DC) content, lipid hydroperoxides (LHP), reduced glutathione (GSH) in the liver mitochondria, the serum activities of aspartate and alanine aminotransferases (AST and ALT) in experimental diabetes mellitus with the correction using a complex compound of germanium with nicotinic acid – MIGU-4 and insulin, insulin alone as well as in comparison with effectiveness of vitamin E supplementation.

Materials and methods. Diabetes was induced in male Wistar rats by intraperitoneal injection of streptozotocin (60.0 mg/kg). MIGU-4 was administered intraperitoneally at a dose of ED50 that was 25.0 mg/kg. Mitochondrial membranes were obtained by differential centrifugation of the liver tissue. In rats with confirmed diabetes, parameters of peroxidation and antioxidant protection were studied by generally accepted biochemical and biophysical methods.

Results. Glucose levels were 29.4 % lower in rats treated with MIGU-4 (25.0 mg/kg) after 8 weeks of streptozotocin-induced diabetes than those in untreated diabetic rats (p < 0.05), while a decrease was 39.0 % (p < 0.05) upon insulin treatment, and 47.2 % (p < 0.05) – with combined use of the drugs. The MDA content in the brain tissue was 3.48 times higher than that in the control (p < 0.05). At the same time, the activities of SOD and CAT were decreased by 46.4 % and 32.0 %, respectively, the activity of GPO was decreased by half (p < 0.05).

In the liver mitochondria, the DC content exceeded that in the control by 53.5 % (p < 0.05), and the MDA and LHP levels were 2.48 times and 31.7 % higher (p < 0.05), respectively. AST activity was almost doubled, ALT activity was 5.48 times increased. Insulin and the biologically active substance MIGU-4 used alone exerted a moderate corrective effect. The combined use of the drugs caused definite therapeutic and preventive effects as the brain content of MDA was 2.4 times decreased, the activity of SOD, CAT and GPO was increased by 45.6 %, 35.2 % and 67.3 % (p < 0.05), respectively. In the liver mitochondria, the DC, MDA, and LHP contents were decreased by 41.0 %, 53.3 %, and 28.4 %, respectively, compared to those in rats with diabetes (p < 0.05).

The activity of SOD and CAT as well as GSH content were increased by 2.7 times, 51.9 %, and 23.0 % (p < 0.05), respectively. AST and ALT activities were 42.2 % and 74.3 % (p < 0.05) reduced, respectively. The combined use of MIGU-4 (25.0 mg/kg) and vitamin E (250.0 mg/kg) caused a decrease in the brain MDA content by 70.1 % (p < 0.05) in experimental rats. The combination of MIGU-4 and vitamin E increased the activity of GPO by 58.3 % (p < 0.05) as compared to rats with diabetes, indicating cumulative effects of these drugs.

Conclusions. The use of MIGU-4 prevents the occurrence of oxidant stress manifestations in the brain tissue and liver mitochondria in streptozotocin-induced diabetes. The corrective effect size of MIGU-4 (25.0 mg/kg) corresponds to that of vitamin E (250.0 mg/kg).

 

Author Biographies

V. Y. Kresiun, Odesa National Medical University, Ukraine

MD, PhD, DSc, Professor of the Department of Pharmacology and Pharmacognosy, Academician of the National Academy of Medical Sciences of Ukraine

N. Al-Nadawi Javad, Odesa National Medical University, Ukraine

MD, Postgraduate student of the Department of Pharmacology and Pharmacognosy

References

Fedoruk, R. S., Kovalchuk, I. I., Mezentseva, L. M., Tesarivska, U. I., Pylypets, A. Z., & Kaplunenko, V. H. (2022). Spoluky hermaniiu ta yikhnia rol v orhanizmi tvaryn [Germanium compounds and their role in the animal body]. Biolohiia tvaryn, 24(1), 50-60. [in Ukrainian]. https://doi.org/10.15407/animbiol24.01.050

Azumi, J., Shimada, Y., Takeda, T., Aso, H., & Nakamura, T. (2022). The Organogermanium Compound 3-(Trihydroxygermyl) Propanoic Acid (THGP) Suppresses Inflammasome Activation Via Complexation with ATP. International journal of molecular sciences, 23(21), 13364. https://doi.org/10.3390/ijms232113364

Mertens, R. T., Parkin, S., & Awuah, S. G. (2020). Exploring six-coordinate germanium(IV)-diketonate complexes as anticancer agents. Inorganica chimica acta, 503(1), 119375. https://doi.org/10.1016/j.ica.2019.119375

Nakamura, T., Takeda, T., & Tokuji, Y. (2014). The Oral Intake of Organic Germanium, Ge-132, Elevates α-Tocopherol Levels in the Plas-ma and Modulates Hepatic Gene Expression Profiles to Promote Immune Activation in Mice. International journal for vitamin and nutrition research, 84(3-4), 183-195. https://doi.org/10.1024/0300-9831/a000205

Grushka, N. G., Pavlovych, S. I., Kondratska, O. A., Pilkevcih, N. O., & Yanchii, R. I. (2019). Protektyvna diia tsytratu hermaniiu na funktsionalnyi stan imunokompetentnykh klityn ta aktyvnist neitrofiliv pry zapalenni, indukovanomu lipopolisakharydom [The protective effect of germanium citrate on functional state of immune cells and neutrophil activity under the condition of lipolysaccharide induced inflammation]. Fiziolohichnyi zhurnal, 65(6), 43-50. [in Ukrainian]. https://doi.org/10.15407/fz65.06.043

Kresyun, N. V., & Son, G. O. (2017). Stan perekysnoho okysnennia lipidiv i antyradykalnoho zakhystu pry eksperymentalnomu tsukrovomu diabeti ta yoho medykamentoznii korektsii [The state of lipids peroxidation and antiradical protection in experimental diabetes and its pharmacological correction. Dosiahnennia biolohii ta medytsyny, (1), 4-9. [in Ukrainian].

Yang, H., Fan, S., Song, D., Wang, Z., Ma, S., Li, S., Li, X., Xu, M., Xu, M., & Wang, X. (2013). Long-term streptozotocin-induced diabetes in rats leads to severe damage of brain blood vessels and neurons via enhanced oxidative stress. Molecular Medicine Reports, 7(2), 431-440. https://doi.org/10.3892/mmr.2012.1227

Kresyun, N. V., Godlevsky L. S., & Son G. O. (2017). Stan membran mitokhondrii pechinky shchuriv pry tsukrovomu diabeti ta medykamentoznii korektsii [The state of mitochondria membrane of rat hepatocytes in experimental diabetes and pharmacological treatment]. Odeskyi medychnyi zhurnal, (1), 5-12. [in Ukrainian].

Omer, A. B., Dalhat, M. H., Khan, M. K., Afzal, O., Altamimi, A. S. A., Alzarea, S. I., Almalki, W. H., & Kazmi, I. (2022). Butin Mitigates Memory Impairment in Streptozotocin-Induced Diabetic Rats by Inhibiting Oxidative Stress and Inflammatory Responses. Metabolites, 12(11), 1050. https://doi.org/10.3390/metabo12111050

Al-Nadawi, N., & Kresyun, V. Y. (2023). Neirodeheneratyvni zminy sitkivky shchuriv z khronichnoiu formoiu epileptychnoho syndromu za umovy zastosuvannia niatsyn-oksietylidendyfosfonatohermanatu (MIHU-4) [Neurodegenerative changes in the retina of rats with a chronic form of epileptic syndrome under the condition of using niacin-oxyethylidenediphosphonategermanate (MIGU-4)]. Oftalmologicheskii zhurnal, (2), 26-30. [in Ukrainian]. https://doi.org/10.31288/oftalmolzh202322630

Janero, D. R., & Burghardt, B. (1989). Thiobarbituric acid-reactive malondialdehyde formation during superoxide-dependent, iron-catalyzed lipid peroxidation: influence of peroxidation conditions. Lipids, 24(2), 125-131. https://doi.org/10.1007/BF02535249

Lapovets, L. E. (Ed.). (2021). Klinichna laboratorna diahnostyka [Clinical laboratory diagnostics (2nd ed). Kyiv: Medicine. [in Ukrainian].

Kucherenko, M. E., Babenyuk, Y. D., & Voitsitskyi, V. M. (2001). Suchasni metody biokhimichnykh doslidzhen [Modern methods of biochemical research]. Kyiv: Phytosocial Center. [in Ukrainian].

Weydert, C. J., & Cullen, J. J. (2010). Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nature protocols, 5(1), 51-66. https://doi.org/10.1038/nprot.2009.197

Evelson, P., Susemihl, C., Villarreal, I., Llesuy, S., Rodríguez, R., Peredo, H., Lemberg, A., Perazzo, J., & Filinger, E. (2005). Hepatic morphological changes and oxidative stress in chronic streptozotocin-diabetic rats. Annals of hepatology, 4(2), 115–120.

Almulathanon, A. A. Y., Mohammad, J. A., & Allwash, T. A. (2021). Evaluation the effects of insulin on oxidant/antioxidant status in type 1 diabetic patients. Pharmacia, 68(3), 699-704. https://doi.org/10.3897/pharmacia.68.e70495

Trujeque-Ramos, S., Castillo-Rolón, D., Galarraga, E., Tapia, D., Arenas-López, G., Mihailescu, S., & Hernández-López, S. (2018). Insulin Regulates GABAA Receptor-Mediated Tonic Currents in the Prefrontal Cortex. Frontiers in neuroscience, 12, 345. https://doi.org/10.3389/fnins.2018.00345

Korol, S. V., Tafreshiha, A., Bhandage, A. K., Birnir, B., & Jin, Z. (2018). Insulin enhances GABAA receptor-mediated inhibitory currents in rat central amygdala neurons. Neuroscience letters, 671, 76-81. https://doi.org/10.1016/j.neulet.2018.02.022

Bayramoglu, G., Senturk, H., Bayramoglu, A., Uyanoglu, M., Colak, S., Ozmen, A., & Kolankaya, D. (2014). Carvacrol partially reverses symptoms of diabetes in STZ-induced diabetic rats. Cytotechnology, 66(2), 251-257. https://doi.org/10.1007/s10616-013-9563-5

Yazdi, H. B., Hojati, V., Shiravi, A., Hosseinian, S., Vaezi, G., & Hadjzadeh, M. A. (2019). Liver Dysfunction and Oxidative Stress in Streptozotocin-Induced Diabetic Rats: Protective Role of Artemisia Turanica. Journal of pharmacopuncture, 22(2), 109-114. https://doi.org/10.3831/KPI.2019.22.014

Wada, T., Hanyu, T., Nozaki, K., Kataoka, K., Kawatani, T., Asahi, T., & Sawamura, N. (2018). Antioxidant Activity of Ge-132, a Synthetic Organic Germanium, on Cultured Mammalian Cells. Biological & pharmaceutical bulletin, 41(5), 749-753. https://doi.org/10.1248/bpb.b17-00949

Downloads

Published

2023-09-28

How to Cite

1.
Kresiun VY, Al-Nadawi Javad N. State of peroxidation in the brain and liver in experimental diabetes and its correction possibility with niacin-oxyethylendiphosphonatogermanate. Zaporozhye Medical Journal [Internet]. 2023Sep.28 [cited 2024Nov.18];25(5):409-15. Available from: http://zmj.zsmu.edu.ua/article/view/283612

Issue

Vol. 25 No. 5 (2023): Zaporozhye medical journal

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)